Big Pharma Split (TSX:PRM.PR.A.PFD) Total Payout Ratio : -11.52 (As of Apr. 29, 2024)

View and export this data going back to 2017. Start your Free Trial

What is Big Pharma Split Total Payout Ratio?

Total Payout Ratio is the percent a company has paid to its shareholders through net repurchase of shares and dividends based on its Net Income.

Big Pharma Split's current Total Payout Ratio is -11.52.

Big Pharma Split Total Payout Ratio Historical Data

The historical data trend for Big Pharma Split's Total Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Big Pharma Split Total Payout Ratio Chart

Big Pharma Split Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Payout Ratio

Get a 7-Day Free Trial

2.23

-15.75

-1.13

0.93

-11.52

Big Pharma Split Semi-Annual Data
	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Total Payout Ratio	Get a 7-Day Free Trial								-0.69	0.44	3.99	-9.94	-23.04

Competitive Comparison of Big Pharma Split's Total Payout Ratio

For the Asset Management subindustry, Big Pharma Split's Total Payout Ratio, along with its competitors' market caps and Total Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Big Pharma Split's Total Payout Ratio Distribution in the Asset Management Industry

For the Asset Management industry and Financial Services sector, Big Pharma Split's Total Payout Ratio distribution charts can be found below:

* The bar in red indicates where Big Pharma Split's Total Payout Ratio falls into.

Big Pharma Split Total Payout Ratio Calculation

Total Payout Ratio is a measurement showing the proportion of earnings a company pays shareholders in the form of dividends and net stock repurchases.

Big Pharma Split's Total Payout Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Total Payout Ratio	=	- (Repurchase of Stock	+	Issuance of Stock	+	Cash Flow for Dividends)	/	Net Income
	=	- (-5.322	+	0	+	-2.109)	/	-0.645
	=	-11.52

Big Pharma Split's Total Payout Ratio for the quarter that ended in Dec. 2023 is calculated as

Total Payout Ratio	=	- (Repurchase of Stock	+	Issuance of Stock	+	Cash Flow for Dividends)	/	Net Income
	=	- (-0.807	+	0	+	-0.99)	/	-0.078
	=	-23.04

Big Pharma Split Total Payout Ratio Related Terms

Thank you for viewing the detailed overview of Big Pharma Split's Total Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Big Pharma Split (TSX:PRM.PR.A.PFD) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Big Pharma Split Corp (TSX:PRM.PR.A.PFD) » Definitions » Total Payout Ratio

Comparable Companies

Traded in Other Exchanges

PRM:Canada

Address

610 Chartwell Road, Suite 204, Oakville, ON, CAN, L6J 4A5

Website

https://www.harvestportfolios.com

Big Pharma Split Corp is a mutual fund corporation. Its investment objective is to provide shareholders with fixed cumulative preferential quarterly cash distributions, and regular monthly cash distributions. The company has a presence in the United States; Switzerland; France and United Kingdom.

Big Pharma Split (TSX:PRM.PR.A.PFD) Headlines

No Headlines